Viatris Inc. (NASDAQ:VTRS) Q1 2026 Earnings Call Transcript
Operator: Good morning, and welcome to the Viatris First Quarter 2026 Earnings Call. [Operator Instructions] Please note this event is being recorded.
Viatris Inc (VTRS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 33,500,000 | $452,585,000 | +32% | 4.79% |
| 2. | Deerfield Management James E. Flynn | 20,206,170 | $272,985,357 | 3.22% | |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 9,349,817 | $126,316,029 | +2221% | 0.13% |
| 4. | Glenview Capital Larry Robbins | 9,087,244 | $122,768,666 | -19% | 3.08% |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 8,545,196 | $115,445,598 | -2% | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.43 | 213 | $2,220.63 | 1,183 | 2025-11-03 | Filing | |
| $10.42 | 286 | $2,980.98 | 970 | 2025-08-27 | Filing | |
| $9.99 | 22,000 | $219,740.40 | 314,807 | 2025-08-12 | Filing | |
| $8.94 | 60,000 | $536,262.00 | 292,807 | 2025-05-12 | Filing | |
| $9.01 | 19 | $171.13 | 94,960 | 2023-10-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.28 | 21,350 | $283,538.68 | 366,288 | 2026-03-23 | Filing | |
| $10.25 | 7,032 | $72,044.95 | 35,299 | 2025-09-11 | Filing | |
| $12.88 | 26,925 | $346,686.30 | 126,901 | 2024-11-11 | Filing | |
| $11.66 | 139,681 | $1,628,163.64 | 505,838 | 2024-09-12 | Filing | |
| $11.71 | 60,319 | $706,552.64 | 0 | 2024-09-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 84,359,804 | $1,139,700,963 | 0.02% | |
| 2. | 78,211,191 | $1,056,633,206 | 4.85% | |
| 3. | 74,716,631 | $1,009,421,685 | 0.02% | |
| 4. | 53,911,237 | $728,340,812 | 0.03% | |
| 5. | 52,233,699 | $705,677,273 | 0.02% |
News See All
10 Best Medical Stocks to Buy Under $30
On April 28, Reuters reported that the US Food and Drug Administration has introduced a new pilot program that would allow the agency to monitor clinical trial data in real time.
13 Extreme Value Stocks to Buy Now
The stock market gains over the last few years have been dominated by major tech companies as well as artificial intelligence stocks.
10 Best Stocks Under $20 to Buy According to Hedge Funds
On March 12, CNN reported that stocks are falling while oil prices are rising as tensions with Iran fuel concerns about higher energy costs and disruptions to the global economy.
Viatris (VTRS) Delivers Solid 2025 Growth and Robust Cash Flow at Deep Value
Viatris Inc. (NASDAQ:VTRS) is one of the dirt cheap stocks to buy now.
12 Dirt Cheap Stocks to Buy Now
On February 23, Pierre Ouimet, head investment strategist at UBS Canada, joined BNN Bloomberg to discuss the markets and provide a spotlight on undervalued sectors.
UBS Raises Viatris (VTRS) Price Target as Cost Savings and Growth Outlook Improve
On February 27, UBS raised its price recommendation on Viatris Inc. (NASDAQ:VTRS) to $20 from $18. It maintained a Buy rating on the stock.
13 Best March Dividend Stocks to Buy
An American asset management company, Nuveen, said dividend income can serve as a steady complement to capital appreciation, especially during periods of market uncertainty.
Viatris Inc. (NASDAQ:VTRS) Q4 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Viatris Inc. Q4 2025 earnings call. Today, all participants are in a listen-only mode.
Viatris Inc. (VTRS) FDA Accepts sNDA for Presbyopia Treatment with October PDUFA Date
Viatris Inc. (NASDAQ:VTRS) is one of the most undervalued stocks under $30 to buy.
Hedge Fund Resource Center